Literature DB >> 28828469

Management of Parkinson Disease in 2017: Personalized Approaches for Patient-Specific Needs.

Michael S Okun1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28828469     DOI： 10.1001/jama.2017.7914

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  10 in total

Review 1.  An Update on the Critical Role of α-Synuclein in Parkinson's Disease and Other Synucleinopathies: from Tissue to Cellular and Molecular Levels.

Authors:  Iris N Serratos; Elizabeth Hernández-Pérez; Carolina Campos; Michael Aschner; Abel Santamaría
Journal:  Mol Neurobiol       Date:  2021-11-08       Impact factor: 5.682

2.  BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson's Disease.

Authors:  D Luke Fischer; Peggy Auinger; John L Goudreau; Allyson Cole-Strauss; Karl Kieburtz; Jordan J Elm; Mallory L Hacker; P David Charles; Jack W Lipton; Barbara A Pickut; Caryl E Sortwell
Journal:  Neurotherapeutics       Date:  2020-11-19       Impact factor: 7.620

3.  Personalized Dietary Management of Overweight and Obesity Based on Measures of Insulin and Glucose.

Authors:  Mads F Hjorth; Yishai Zohar; James O Hill; Arne Astrup
Journal:  Annu Rev Nutr       Date:  2018-06-01       Impact factor: 9.323

4.  An 8-Week Low-Intensity Progressive Cycling Training Improves Motor Functions in Patients with Early-Stage Parkinson's Disease.

Authors:  Hsiu Chen Chang; Chin Song Lu; Wei Da Chiou; Chiung Chu Chen; Yi Hsin Weng; Ya Ju Chang
Journal:  J Clin Neurol       Date:  2018-04       Impact factor: 3.077

Review 5.  Update on the Management of Parkinson's Disease for General Neurologists.

Authors:  Zvezdan Pirtošek; Ovidiu Bajenaru; Norbert Kovács; Ivan Milanov; Maja Relja; Matej Skorvanek
Journal:  Parkinsons Dis       Date:  2020-03-26

6.  Physical activities and risk of neurodegenerative diseases: A two-sample Mendelian randomization study.

Authors:  Qiao Liao; Jian He; Kun Huang
Journal:  Front Aging Neurosci       Date:  2022-09-23       Impact factor: 5.702

7.  Patient-Centered Identification of Meaningful Regulatory Endpoints for Medical Devices to Treat Parkinson's Disease.

Authors:  Heather L Benz; Brittany Caldwell; John P Ruiz; Anindita Saha; Martin Ho; Stephanie Christopher; Dawn Bardot; Margaret Sheehan; Anne Donnelly; Lauren McLaughlin; Brennan Mange; A Brett Hauber; Katrina Gwinn; William J Heetderks; Murray Sheldon
Journal:  MDM Policy Pract       Date:  2021-07-02

Review 8.  Evidence Supports PA Prescription for Parkinson's Disease: Motor Symptoms and Non-Motor Features: A Scoping Review.

Authors:  Yi-Chen Cheng; Chun-Hsien Su
Journal:  Int J Environ Res Public Health       Date:  2020-04-22       Impact factor: 3.390

Review 9.  Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson's Disease: Past, Present, and Future.

Authors:  Yu-Yan Tan; Peter Jenner; Sheng-Di Chen
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.568

10.  Ethical Aspects of Personal Science for Persons with Parkinson's Disease: What Happens When Self-Tracking Goes from Selfcare to Publication?

Authors:  Sara Riggare; Maria Hägglund; Annelien L Bredenoord; Martijn de Groot; Bastiaan R Bloem
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.